New research suggests hormone therapy may increase autoimmune disease risk in postmenopausal women. Dr Jiang discusses early findings and clinical implications.
Xuezhi (Daniel) Jiang, MD, PhD
Advertisement
Xuezhi Daniel Jiang, MD, PhD, professor of obstetrics and gynecology at the Drexel University College of Medicine.
Articles by Xuezhi (Daniel) Jiang, MD, PhD
Jiang shares how to use new autoimmune risk data responsibly—identifying high-risk patients while avoiding unnecessary hormone therapy phobia.
Dr. Daniel Jiang shares unexpected research findings showing hormone therapy increased autoimmune disease risk across 15 of 17 conditions in postmenopausal women.
TMS 2025: Jiang explains why he investigated hormone therapy's effect on autoimmune disease risk in postmenopausal women.
Advertisement
Latest Updated Articles
Hormone Therapy Linked to Increased Autoimmune Disease RiskPublished: October 28th 2025 | Updated:
- Hormone Therapy and Autoimmune Disease Risk in Postmenopausal Women, With Xuezhi Daniel Jiang, MD, PhD
Published: October 27th 2025 | Updated:
- Xuezhi Daniel Jiang, MD, PhD, on Counseling Postmenopausal Women on Autoimmune Disease Risk Without Creating Hormone Therapy Phobia
Published: October 28th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis
2
Large-Scale Study Challenges Previous Research on Menopause and Brain Structure
3
Vitamin D Dosing Tailored to Optimal Levels Reduced Risk of Recurrent MI by More Than Half
4
Menopause Treatment in Real-World Practice: Ob/Gyn Anna Christine Cochrane, MD Highlights New Research
5
